Virtual Practice
Recommend

Dr. Omar Eton

Internal Medicine - Hematology & Oncology
Boston, MA
About
Insights
Network
Checklists
Welcome!
About me
I specialize in
Internal Medicine - Hematology & Oncology
Internal Medicine
I have been in practice
36 years
I am licensed to see patients from
Texas
I speak
Spanish
French
I'm known for
Doctor
Votes
Member
Votes
GI cancer
--
Unranked
Immunotherapy
--
Unranked
Medical research
--
Unranked
Recommend me
My answers and insights have
Saved 1 life
Helped 66,180 people
Received 162 doctor agrees
Received 43 thanks
Here are kind words from others
Dr. Eton is an amazing doctor! #nationaldoctorsday2015 #virtualflower1
Dr. Eton is an amazing doctor! #nationaldoctorsday2015 #virtualflower1
Recommend me
I am located at
Boston University Medical Center
830 Harrison Ave
Boston , MA 02118
Office hours
Mon 1:00pm - 5:00pm
Wed 9:00am - 5:00pm
Fri 9:00am - 5:00pm
Accepted Insurance Plans
Blue Cross Blue Shield Of Massachusetts
Aetna Life Insurance Company
Harvard Pilgim Health Care
TUFTS Health Plan
I was educated and trained at
Medical / Graduate School
New York University School of Medicine, NY
1983
Fellowships
Hematology And Oncology Memorial Sloan Kettering Cancer Center
I've won the following awards
Top Oncologist and Hematologist , Massachusetts
Fall 2014
Meritorious Service Medal, United States Air Force
American Cancer Society Fellow
I've published
Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics.
Molecular cancer therapeutics, 9, 2844-52 (2010)
T Macarulla, A Cervantes, E Elez, E Rodríguez-Braun, J Baselga, S Roselló, G Sala, I Blasco, H Danaee, Y Lee, J Ecsedy, V Shinde, A Chakravarty, D Bowman, H Liu, O Eton, H Fingert, J Tabernero
Melanoma brain metastasis: overview of current management and emerging targeted therapies.
Expert review of neurotherapeutics, 12, 1207-15 (2012)
E Fonkem, E J Uhlmann, S R Floyd, A Mahadevan, E Kasper, O Eton, E T Wong
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
British journal of cancer, 99, 734-40 (2008)
T Macarulla, A Cervantes, E Elez, E Rodríguez-Braun, J Baselga, S Roselló, G Sala, I Blasco, H Danaee, Y Lee, J Ecsedy, V Shinde, A Chakravarty, D Bowman, H Liu, O Eton, H Fingert, J Tabernero